ROUND TABLE · 2016

2016 – : ALGERIA 2020 & Biotechnology: What future & model for Algeria?

ALGERIA 2020 & Biotechnology: What future & model for Algeria?

2016-roundtables-a5626458

About this session

The need to communicate a clear vision, a political decision set out with a roadmap and concrete projects in the short, medium and long terms..

The presence of a dedicated interlocutor and decision-maker who would be the vis-à-vis the different actors for the biotechnology project like biopolis in Singapore

The importance of government incentive programs to encourage the private sector to invest, build a real biotechnology industry and encourage research in Algeria.

Attending experts

DR-Siew-HWA-60f04115

Dr. Siew Hwa ONG

Founder & CEO, Acumen Research Laboratories & Chairman

DRA-MAYRA-RAMOS-ddf175d4

Dra.C. Mayra Ramos Suzarte

DEEPANWITA-CHATTOPADHYAY-6584ea85

Deepanwita Chattopadhyay

CEO & Chairman IKP Knowledge Park

MIQUEL-BONACHERA-6c849d33

Miquel Bonachera Sierra

CEO AB Bioticts, for ASEBIO

Audience

  • Director General of Pharmacy, MOH, Dr. Hamou Hafed
  • Director General of Health, MOH, Pr. Mohamel l’Hadj
  • General Manager of PCH, M’hamed Ayad
  • Director General of Social Security, Djaouad Bourkaib & Dr. Mohamed Lamine Ghanem
  • Director of INSP, Pr. Mokhtar Hasbellaoui
  • Senior management of companies & healthcare sector representative : Novo Nordisk, AstraZeneca, Clinica Group, Merck, ANPP, Deloitte, Sevier
  • Director Geenral of the Biotechnology Center